Navigation Links
Betty Ford Center, Hazelden Foundation Pursue Possible Alliance
Date:6/4/2013

CENTER CITY, Minn., June 4, 2013 /PRNewswire-USNewswire/ -- Hazelden Foundation and Betty Ford Center, leaders in addiction treatment, are pursuing a formal alliance.

(Logo: http://photos.prnewswire.com/prnh/20061128/CGTU038LOGO)

Both Hazelden and Betty Ford offer intensive treatment programs for persons addicted to alcohol and/or other drugs.

The boards of both institutions have approved in principle the concept of a formal alliance between the widely-respected institutions.

According to Hazelden's Board of Trustees Chair Judge Susan Fox Gillis , the 2014 full implementation of the Affordable Care Act (ACA) is one of the principle drivers of the affiliation conversations.

Judge Gillis says the ACA presents the treatment field with both challenges and opportunities.

"The good news is that many more Americans who desperately need help will be eligible to receive quality treatment for their addiction to alcohol or other drugs," she says.  "The challenge will be to pay for that expanded coverage and service.  At this stage it appears that institutionally, only the strong will survive and thrive.  Both Betty Ford and Hazelden are recognized as industry leaders, but the fact is we'd be even stronger if we collaborated on a formal basis."

Betty Ford Center Board of Directors Chair Dr. Mary Pattiz says Hazelden and Betty Ford are natural partners.

"We've been as one since day one," she says. "Before Betty Ford Center opened its doors in October, 1982, we looked to Hazelden.  Our co-founders, First Lady Betty Ford and Ambassador Leonard Firestone , studied what's still referred to as `the Hazelden model.'  It was and is our inspiration, and for more than 30 years we've worked side by side as philosophical partners in providing quality care to alcoholics, addicts, and their families."

At both Betty Ford and Hazelden, the Twelve Steps of Alcoholics Anonymous provide the foundation for treatment protocols, which are abstinence-based. 

Judge Gillis, says one of the top priorities – if not the top priority -- as collaboration discussions move forward, will be ensuring that the extraordinary legacy of Betty Ford continues to be honored.

"Mrs. Ford is a hero to us all," she says. "When she so bravely went public about her own addiction, she put a face on this disease.  She brought this disease out of the closet.  By insisting that half the treatment beds at the center named after her be reserved for women, she also guaranteed that women would no longer be `the forgotten gender.'"

Judge Gillis adds that members of the Ford family are a critical part of the ongoing collaboration conversations. 

The Betty Ford Center, a licensed addiction treatment hospital founded in 1982, is based in Rancho Mirage, California.  In February this year it achieved the 100,000 benchmark; that's how many men, women and children have benefited from its many treatment programs.  Betty Ford Center also offers its unique Children's Program in Denver and Dallas/Ft. Worth, and is in the forefront of teaching medical professionals about the disease of addiction and the promise of treatment.

Hazelden Foundation is a national nonprofit organization founded in 1949.  Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family and professional needs, including substance abuse treatment and continuing care for youth and adults, research, higher education, public education and advocacy and publishing.  It currently has facilities in Minnesota, Oregon, Illinois, New York and Florida.


'/>"/>
SOURCE Hazelden Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Sciences Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
2. Disability days at Reliant Center, August 3-5, 2012
3. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
4. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinsons Disease
5. National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill
6. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
7. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
8. National Patient Advocate Foundations Annual Capitol Hill Briefing Focuses on Patient Access Barriers to Life-Saving Medicines Placed on Specialty Tiers by Commercial Insurance Plans and Medicare
9. Epilepsy Foundation To Present Epilepsy Therapy Project Lifetime Accelerator Award To Henrik Klitgaard, Ph.D., Recognizing Contributions To New Therapies
10. Cardinal Health Foundation Invites Local Non-profit Organizations To Apply For Grants To Prevent Prescription Drug Abuse
11. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology:
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):